Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Thyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients With Hyperthyroidism
source: Annals of Surgical Oncology
year: 2014
authors: David F Schneider, Ratnam Nookala, Taylor J Jaraczewski, Herbert Chen, Carmen C Solorzano, Rebecca S Sippel
summary/abstract:Objective:
The purpose of this study was to determine how the timing of thyroidectomy influenced postoperative weight change.
Methods:
We conducted a two-institution study, identifying patients treated with total thyroidectomy for hyperthyroidism. Patients were classified as ‘early’ if they were referred for surgery as the first treatment option, or ‘delayed’ if they were previously treated with radioactive iodine (RAI). Groups were compared with the Student’s t-test or χ (2) test where appropriate.
Results:
There were 204 patients undergoing thyroidectomy for hyperthyroidism. Of these, 171 patients were classified as early and 33 were classified as delayed. Overall, patients gained 6.0 % ± 0.8 of their preoperative body weight at last follow-up. Preoperative body mass indexes (BMIs) were similar between groups (p = 0.98), and the median follow-up time was 388 days (range 15-1,584 days). Both groups gained weight until they achieved a normal thyroid-stimulating hormone (TSH) postoperatively. After achieving a normal TSH, the early group stabilized or lost weight (-0.2 lbs/day), while the delayed group continued to gain weight (0.02 lbs/day; p = 0.61). At last follow-up, there were significantly more patients in the delayed group who increased their BMI category compared with the early group (42.4 vs. 21.6 %; p = 0.01). Twice as many patients in the delayed group moved up or into an unhealthy BMI category (overweight or obese) compared with the early group (39.4 vs. 19.3 %; p = 0.01).
DOI: 10.1245/s10434-014-3542-8
read more
myBinderRelated Content
-
Post-Partum and Non-Post-Partum Relapsing Graves’ Hyperthyroidism Display Different Response to Anti-Thyroid D...Design: Graves’ disease (GD) patients...
-
Risk Factors For Developing Thyroid-Associated Ophthalmopathy Among Individuals with Graves’ DiseaseImportance: Thyroid-associated ophthalm...
-
Cost-Utility Analysis Comparing Radioactive Iodine, Anti-Thyroid Drugs and Total Thyroidectomy for Primary Treatment...Objective: Little data is in existence ...
-
How To Cure Graves’ Disease – Dr. Raymond Douglashttps://www.youtube.com/watch?v=Zv8g8EFk...
-
Substituting Potassium Iodide for Methimazole as the Treatment for Graves’ Disease During the First Trimester ...Background: To control hyperthyroidism ...
-
The Brazilian Consensus for the Diagnosis and Treatment of Hyperthyroidism: Recommendations by the Thyroid Departmen...Introduction: Hyperthyroidism is charac...
-
Treatment Choice, Satisfaction and Quality of Life in Patients With Graves’ DiseaseBackground: Thyrotoxicosis, most often ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google